6 Jefferies Group Deciphera Pharmaceuticals Trades
Jefferies Group's position in Deciphera Pharmaceuticals is currently worth $21 Million. That's 0.48% of their equity portfolio (43rd largest holding). The first Deciphera Pharmaceuticals trade was made in Q4 2022. Since then Jefferies Group bought shares three more times and sold shares on two occasions. The stake costed the investor $12.9 Million, netting the investor a gain of 63% so far.
News about Deciphera Pharmaceuticals Inc and Jefferies Group
Thinking about buying stock in Jounce Therapeutics, Kingsoft Cloud, Smartsheet, Oatly Group, or Deciphera Pharmaceuticals?
NEW YORK , March 15, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JNCE, KC, SMAR, OTLY, and DCPH. … Full story available on B...
Jefferies Financial Group Brokers Decrease Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Stock analysts at Jefferies Financial Group cut their FY2021 earnings per share (EPS) estimates for shares of ...